Miriam O’Donnell

The pharma industry is looking to novel technologies for answers to its challenges in all areas of drug development. Such technologies must be able to adhere to GMP for both…

Liquid-filled capsules offer significant benefits for active pharmaceutical ingredients (APIs) presenting formulation or manufacturing challenges. Their use is beneficial throughout the different phases of drug development, from preclinical to commercialization.…

Digital transformation initiatives can often times result in false starts and inefficiencies by overemphasizing “paperless” environments. Such endeavors focus on identifying and converting paper-based forms and procedures to electronic means,…

The competitive landscape in early drug development is especially prominent in meeting unmet patient needs. In areas where there is a more urgent need to develop orphan drugs, such as…